Yue Zhao

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (105)

• Comprehensive immunological profiling across diverse clinical and pathological subtypes of lung adenocarcinoma
  Journal of the National Cancer Center 2026 DOI: 10.1016/j.jncc.2026.02.004
  +Save
• Integrative clinico-molecular analysis reveals actionable subtypes and biomarkers in lung adenocarcinoma
  Cell Discovery 2026 DOI: 10.1038/s41421-025-00863-4
  +Save
• Data from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
  2025 DOI: 10.1158/0008-5472.c.6780363
  +Save
• Supplementary Material from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
  2025 DOI: 10.1158/0008-5472.30701471
  +Save
• Table S1 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
  2025 DOI: 10.1158/0008-5472.30701468
  +Save
• Table S2 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
  2025 DOI: 10.1158/0008-5472.30701465
  +Save
• Table S3 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
  2025 DOI: 10.1158/0008-5472.30701462
  +Save
• Table S4 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
  2025 DOI: 10.1158/0008-5472.30701459
  +Save
• Table S5 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
  2025 DOI: 10.1158/0008-5472.30701456
  +Save
• Table S6 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
  2025 DOI: 10.1158/0008-5472.30701453
  +Save
• Table S7 from Elevated Mast Cell Abundance Is Associated with Enrichment of CCR2+ Cytotoxic T Cells and Favorable Prognosis in Lung Adenocarcinoma
  2025 DOI: 10.1158/0008-5472.30701450
  +Save
• Targeting the cholinergic-astrocyte axis: A novel strategy for brain metastasis prevention in lung adenocarcinoma
  Cancer Letters 2025 DOI: 10.1016/j.canlet.2025.217870
  +Save
• Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinoma
  Signal Transduction and Targeted Therapy 2025 DOI: 10.1038/s41392-025-02306-8
  +Save
• Mast cells boost anti-tumor potency of MAIT cells via inflammasome-dependent secretion of IL-18
  Nature Communications 2025 DOI: 10.1038/s41467-025-61324-w
  +Save
• Genomic and Transcriptomic Dynamics in the Stepwise Progression of Lung Adenocarcinoma
  2024 DOI: 10.21203/rs.3.rs-4977481/v1
  +Save
• Data from Elevated Mast Cell Abundance is Associated with Enrichment of CCR2+ Cytotoxic T cells and Favorable Prognosis in Lung Adenocarcinoma
  2024 DOI: 10.1158/0008-5472.c.6780363.v3
  +Save
• Supplementary Material from Elevated Mast Cell Abundance is Associated with Enrichment of CCR2+ Cytotoxic T cells and Favorable Prognosis in Lung Adenocarcinoma
  2024 DOI: 10.1158/0008-5472.27028000.v1
  +Save
• Supplementary Material from Elevated Mast Cell Abundance is Associated with Enrichment of CCR2+ Cytotoxic T cells and Favorable Prognosis in Lung Adenocarcinoma
  2024 DOI: 10.1158/0008-5472.27028000
  +Save
• Table S1 from Elevated Mast Cell Abundance is Associated with Enrichment of CCR2+ Cytotoxic T cells and Favorable Prognosis in Lung Adenocarcinoma
  2024 DOI: 10.1158/0008-5472.27027997
  +Save
• Table S1 from Elevated Mast Cell Abundance is Associated with Enrichment of CCR2+ Cytotoxic T cells and Favorable Prognosis in Lung Adenocarcinoma
  2024 DOI: 10.1158/0008-5472.27027997.v1
  +Save